Viewing Study NCT06185569


Ignite Creation Date: 2025-12-24 @ 11:00 PM
Ignite Modification Date: 2025-12-25 @ 8:29 PM
Study NCT ID: NCT06185569
Status: RECRUITING
Last Update Posted: 2023-12-29
First Post: 2023-10-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy
Sponsor: Centre Hospitalier Universitaire de Besancon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module